SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,261	1,344	1,524	1,204	899.74	864.22
Revenue Growth	-18.83%	-11.81%	26.54%	33.83%	4.11%	-67.86%
Gross Profit Gross Profit Growth	305.16	351.03	410.67	350.32	291.18	208.09
Operating Income Operating Income Growth	104.02	155.25	198.29	160.3	118.97	73.66
Net Income Net Income Growth	60.12	107.37	534.68	294.72	308.78	55.7
Earnings Per Share EPS Growth	0.50	0.90	4.46	2.69	2.87	0.52
EPS Growth	-87.59%	-79.86%	65.80%	-6.27%	456.63%	-84.53%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Italy Italy Growth	187.66	218.93	274.73	313.71	204.82	244.03
Switzerland Switzerland Growth	109.07	75.39	130.96	71.38	54.46	52.74
Taiwan Taiwan Growth	116.54	114.62	144.95	96.23	109.32	58.52
Germany Germany Growth	100.73	99.66	100	116.08	130.46	92.76
United States United States Growth	145.67	212.36	128.13	127.47	93.27	108.24
Netherlands Netherlands Growth	61.43	60.13	114.26	54.01	-	-
Japan Japan Growth	178.64	208.55	74.38	116.55	110.24	19.51
Spain Spain Growth	18.97	90.32	159.84	33.29	-	30.31
Other Countries Other Countries Growth	259.93	206.04	269.2	203.67	142.26	109.32
Belgium Belgium Growth	-	57.72	127.32	9.94	-	-
Total Total Growth	1,261	1,344	1,524	1,204	899.74	864.22

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	84.07	74.8	692.76	1,031	264.37	692.63
Total Debt Total Debt Growth	1,061	987.18	990.39	1,042	545.38	2.16
Net Cash (Debt) Net Cash Growth	-976.75	-912.39	-297.63	-11.42	-281.01	690.48
Net Cash Growth	-	-	-	-	-	9.52%
Net Cash Per Share Net Cash Per Share Growth	-8.16	-7.62	-2.48	-0.10	-2.61	6.42

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	223.89	220.32	860.52	215.77	296.57	280.28
Capital Expenditures CapEx Growth	-398.32	-610	-946.64	-1,029	-1,168	-771.03
Free Cash Flow Free Cash Flow Growth	-174.44	-389.68	-86.12	-813.59	-871.02	-490.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	24.21%	26.12%	26.95%	29.09%	32.36%	24.08%
Operating Margin	8.25%	11.55%	13.01%	13.31%	13.22%	8.52%
Pretax Margin	6.04%	7.61%	42.45%	30.24%	43.10%	7.58%
Profit Margin	4.77%	7.99%	35.09%	24.47%	34.32%	6.44%
FCF Margin	-13.84%	-29.00%	-5.65%	-67.56%	-96.81%	-56.79%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Dividend Per Share Dividend Per Share Growth	0.750	0.750	1.500	1.250	0.222
Dividend Per Share Growth	-50.00%	-50.00%	20.00%	462.56%	-
Dividend Yield	1.34%	1.57%	1.72%	1.36%	0.28%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	107.51	54.20	20.25	39.25	30.12	143.85
Forward PE	-	47.26	29.34	29.34	39.47	89.36
PS Ratio	5.10	4.33	7.11	9.61	10.34	9.27

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 8, 2026

Data Sources Report a data error